TheNewsRoom | Glaxo Announces Positive Results on Shingles Nerve Pain Drug

All of these words:

The exact phrase:

None of these words:

Categories

Date

Providers

Advanced Search

Learn More

Grab Networks has a huge collection of videos from over 300 news sources. Find in-depth news, embed it to your site, and build community!

About Us
Embedding
Getting Paid
Updates

Connect

The Gallery

Bookmark

Glaxo Announces Positive Results on Shingles Nerve Pain Drug

October 05, 2009

GlaxoSmithKline (GSK) and XenoPort (XNPT) said today that results from a Phase II clinical trial of a drug to treat nerve pain associated with post-herpetic neuralgia met its primary endpoint. The adult patients, who had had inadequate response to doses of 1800 milligrams of gabapentin, demonstrated a statistically significant improvement in pain on a 3600 milligram per day dose of the Glaxo drug, as compared to 1200 per day.